Portal de Periódicos da CAPES

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

2017; National Comprehensive Cancer; Volume: 15; Issue: 6 Linguagem: Inglês

10.6004/jnccn.2017.0100

1540-1413

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam B. Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven Hancock, Michael R. Harrison, Won Kim, Christos E. Kyriakopoulos, Chad A. LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey A. Sosman, Mary A. Dwyer, Rashmi Kumar,

Renal cell carcinoma treatment

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non–clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.